Picture of Johnson & Johnson logo

JNJ Johnson & Johnson Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapNeutral

Annual cashflow statement for Johnson & Johnson, fiscal year end - December 28th, USD millions except per share, conversion factor applied.

2022
January 2nd
2023
December 31st
2023
January 1st
2024
December 29th
2025
December 28th
Period Length:12 M12 M12 M12 M
Source:10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinal
fx
Preliminary
Net Income/Starting Line20,87835,15317,94114,066
Depreciation
Deferred Taxes
Non-Cash Items1,459-18,1611,9573,207
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital-4,2382,507-4,0111,837
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities23,41022,79121,19424,266
Capital Expenditures-3,652-4,543-4,009-4,424
Purchase of Fixed Assets
Other Investing Cash Flow Items-5,0315,421-8,362-14,175
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-8,683878-12,371-18,599
Financing Cash Flow Items395-1,60265-736
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-14,047-15,825-8,871-3,132
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash5027,732-3602,246